Nehru Centre in Mumbai has unveiled an AI‑driven system that can accurately identify early signs of Alzheimer’s disease. The innovation promises to transform neurological care across India.

  • Nehru Centre has built an AI‑based brain‑scan platform.
  • The system detects early Alzheimer’s markers with over 90% accuracy.
  • Potential to revolutionize early‑intervention strategies in India.

Introducing the technology – Nehru Centre, Mumbai, under the leadership of Director Dr. Ananya Sharma, has launched a smart detection system that fuses machine‑learning algorithms with high‑resolution MRI and PET imaging to spot the subtle brain changes indicative of early‑stage Alzheimer’s.

The proprietary algorithm was trained on a massive dataset of anonymised scans, enabling it to recognise patterns invisible to the human eye. In pilot trials, the platform achieved more than 90% sensitivity, outperforming conventional clinical assessments.

Read Also:OnePlus and Nothing Deny Shutdown Rumors, Issue Official Statements

Pilot results – Over a six‑month period, 500 volunteers were screened. The system flagged 45 individuals as high‑risk, allowing clinicians to initiate preventive therapies that could slow disease progression.

The project receives funding from the Ministry of Health and Family Welfare and collaborative partners such as the World Health Organization. International partnerships have ensured that the technology meets global regulatory standards.

Global context – Alzheimer’s disease is projected to cost the world economy more than $2 trillion by 2025. Nehru Centre’s breakthrough positions India as a potential leader in affordable, AI‑enabled neuro‑diagnostics.

Historical Background

Traditionally, Alzheimer’s diagnosis in India relied on clinical evaluation and basic imaging, often leading to late detection. The past two decades have seen a digital health surge, with big‑data analytics reshaping disease identification. Nehru Centre’s effort marks the latest stride in this evolution.

Why This Matters

BozokMedia analysis shows that early detection can reduce caregiving costs by up to 30% and dramatically improve patient quality of life. This technology will alleviate financial and emotional burdens on families and reshape public‑health strategies.

Dr. Anita Rao, neuroscientist, remarks: "This platform is a game‑changer for early Alzheimer’s detection and sets a new benchmark for Indian healthcare innovation."
Did You Know?: Approximately 4.5% of India’s population currently lives with Alzheimer’s, a figure expected to rise to 10% within the next two decades.

Frequently Asked Questions

Q1: How does the technology work?
A: The AI model analyses brain‑scan images for minute structural alterations that precede clinical symptoms, delivering a risk score to physicians.

Q2: When will it be publicly available?
A: Nehru Centre plans a nationwide rollout in major hospitals by the end of next year, following regulatory clearance.